1. Home
  2. BYFC vs AARD Comparison

BYFC vs AARD Comparison

Compare BYFC & AARD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Broadway Financial Corporation

BYFC

Broadway Financial Corporation

HOLD

Current Price

$8.00

Market Cap

71.7M

Sector

Finance

ML Signal

HOLD

Logo Aardvark Therapeutics Inc.

AARD

Aardvark Therapeutics Inc.

HOLD

Current Price

$5.13

Market Cap

85.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BYFC
AARD
Founded
1946
2017
Country
United States
United States
Employees
N/A
40
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
71.7M
85.7M
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
BYFC
AARD
Price
$8.00
$5.13
Analyst Decision
Buy
Analyst Count
0
9
Target Price
N/A
$15.29
AVG Volume (30 Days)
2.0K
170.2K
Earning Date
04-28-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$184,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
18.71
N/A
52 Week Low
$5.51
$3.35
52 Week High
$8.85
$17.94

Technical Indicators

Market Signals
Indicator
BYFC
AARD
Relative Strength Index (RSI) 50.52 47.74
Support Level $7.69 $4.74
Resistance Level $7.93 $6.01
Average True Range (ATR) 0.16 0.40
MACD 0.03 0.21
Stochastic Oscillator 46.79 63.78

Price Performance

Historical Comparison
BYFC
AARD

About BYFC Broadway Financial Corporation

Broadway Financial Corp is active in the financial services domain. It is a savings and loan holding company in the United States. The Bank's business consists of deposits from the general public and using such deposits, together with borrowings and other funds, to make mortgage loans secured by residential properties and commercial real estate. Its deposits consist of passbook savings accounts, checking accounts, and negotiable order of withdrawal accounts, money market accounts and fixed-term certificates of deposit. The revenue is derived from interest income on loans and investments.

About AARD Aardvark Therapeutics Inc.

Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its product candidate, ARD-101, is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which have initiated a Phase 3 clinical trial for hyperphagia associated with PWS.

Share on Social Networks: